297
Views
21
CrossRef citations to date
0
Altmetric
Immunopathogenesis

Elevated Th17 cell frequencies and Th17/Treg ratio are associated with airway hyperresponsiveness in asthmatic children

, MD, , MD, , MD, , MD, , MD & , MD, PhD
Pages 707-716 | Received 03 Dec 2018, Accepted 31 Mar 2019, Published online: 13 Mar 2020

References

  • Akinbami LJ, Simon AE, Rossen LM. Changing trends in asthma prevalence among children. Pediatrics 2016;137(1):e20152354–2354. doi:10.1542/peds.2015-2354.
  • Charron CB, Pakhalé S. The role of airway hyperresponsiveness measured by methacholine challenge test in defining asthma severity in asthma-obesity syndrome. Curr Opin Allergy Clin Immunol 2016;16(3):218–223. doi:10.1097/ACI.0000000000000272.
  • Muehling LM, Lawrence MG, Woodfolk JA. Pathogenic CD4+ T cells in patients with asthma. J Allergy Clin Immunol 2017;140(6):1523–1540. doi:10.1016/j.jaci.2017.02.025.
  • Ray A, Cohn L. Altering the Th1/Th2 balance as a therapeutic strategy in asthmatic diseases. Curr Opin Investig Drugs 2000;1(4):442–448.
  • Lajoie S, Lewkowich IP, Suzuki Y, Clark JR, Sproles AA, Dienger K, Budelsky AL, Wills-Karp M. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol 2010;11(10):928–935. doi:10.1038/ni.1926.
  • Wakashin H, Hirose K, Maezawa Y, Kagami S, Suto A, Watanabe N, Saito Y, Hatano M, Tokuhisa T, Iwakura Y, et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008;178(10):1023–1032. doi:10.1164/rccm.200801-086OC.
  • Wilson RH, Whitehead GS, Nakano H, Free ME, Kolls JK, Cook DN. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med 2009;180(8):720–730. doi:10.1164/rccm.200904-0573OC.
  • Kudo M, Melton AC, Chen C, Engler MB, Huang KE, Ren X, Wang Y, Bernstein X, Li JT, Atabai K, et al. IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat Med 2012;18(4):547–554. doi:10.1038/nm.2684.
  • Joetham A, Schedel M, O'Connor BP, Kim S, Takeda K, Abbott J, Gelfand EW. Inducible and naturally occurring regulatory T cells enhance lung allergic responses through divergent transcriptional pathways. J Allergy Clin Immunol 2017;139(4):1331–1342. doi:10.1016/j.jaci.2016.06.051.
  • Kim HY, Lee HJ, Chang Y-J, Pichavant M, Shore SA, Fitzgerald KA, Iwakura Y, Israel E, Bolger K, Faul J, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med 2014;20(1):54–61. doi:10.1038/nm.3423.
  • Robinson DS. Regulatory T cells and asthma. Clin Exp Allergy 2009;39(9):1314–1323. doi:10.1111/j.1365-2222.2009.03301.x.
  • Whitehead GS, Wilson RH, Nakano K, Burch LH, Nakano H, Cook DN. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 2012;129(1):207–215. doi:10.1016/j.jaci.2011.08.009.
  • Mays LE, Ammon-Treiber S, Mothes B, Alkhaled M, Rottenberger J, Müller-Hermelink ES, Grimm M, Mezger M, Beer-Hammer S, Stebut E, et al. Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism. J Clin Invest 2013;123(3):1216–1228. doi:10.1172/JCI65351.
  • Huang MT, Dai YS, Chou YB, Juan YH, Wang CC, Chiang BL. Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling. J Immunol 2009;183(7):4745–4754. doi:10.4049/jimmunol.0804371.
  • Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, et al. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function. Nature 2008;453(7192):236–240. doi:10.1038/nature06878.
  • Maneechotesuwan K, Kasetsinsombat K, Wamanuttajinda V, Wongkajornsilp A, Barnes PJ. Statins enhance the effects of corticosteroids on the balance between regulatory T cells and Th17 cells. Clin Exp Allergy 2013;43(2):212–222. doi:10.1111/cea.12067.
  • Jiang H, Wu X, Zhu H, Xie Y, Tang S, Jiang Y. Foxp3+ Treg/Th17 cell imbalance in lung tissues of mice with asthma. Int J Clin Exp Med 2015;8(3):4158–4163.
  • Li C, Sheng A, Jia X, Zeng Z, Zhang X, Zhao W, Zhang W. Th17/Treg dysregulation in allergic asthmatic children is associated with elevated notch expression. J Asthma 2018;55(1):1–7. doi:10.1080/02770903.2016.1266494.
  • Jiang M, Gao Y, Zhong NS, Chen WQ, Guan WJ, Zheng JP. Spirometric reference values for healthy Han children aged 5-15 years in Guangzhou, southern China. Pediatr Pulmonol 2015;50(10):1009–1016. doi:10.1002/ppul.23099.
  • Zheng JP, Gao Y, Song YL, Sun XG, Jiang LF, Wang HW, Li Q, Que CL, Han JN, Zhao GL, et al. Guidelines for pulmonary function test (part iii): histamine and methacholine bronchial provocation test. Chin J Tuberc Respir Dis 2014;37(8):566–571.
  • Guan WJ, Zheng JP, Gao Y, Jiang CY, Xie YQ, An JY, Yu XX, Liu WT, Zhong NS. Leukotriene D4 and methacholine bronchial provocation tests for identifying leukotriene-responsiveness subtypes. J Allergy Clin Immunol 2013;131(2):332–338. doi:10.1016/j.jaci.2012.08.020.
  • Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, et al. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000;161(1):309–329. doi:10.1164/ajrccm.161.1.ats11-99.
  • Dell SD, Bola SS, Foty RG, Marshall LC, Nelligan KA, Coates AL. Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers. Ann ATS 2015;12(3):357–363. doi:10.1513/AnnalsATS.201409-433OC.
  • Vargas-Rojas MI, Ramirez-Venegas A, Limon-Camacho L, Ochoa L, Hernandez-Zenteno R, Sansores RH. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med 2011;105(11):1648–1654. doi:10.1016/j.rmed.2011.05.017.
  • Zhang J, Chu S, Zhong X, Lao Q, He Z, Liang Y. Increased expression of CD4+IL-17+ cells in the lung tissue of patients with stable chronic obstructive pulmonary disease (COPD) and smokers. Int Immunopharmacol 2013;15(1):58–66. doi:10.1016/j.intimp.2012.10.018.
  • Zeng Z, Lin X, Zheng R, Zhang H, Zhang W. Celastrol alleviates airway hyperresponsiveness and inhibits Th17 responses in obese asthmatic mice. Front Pharmacol 2018;9:49doi:10.3389/fphar.2018.00049.
  • Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T. Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001;182(1):18–32. doi:10.1034/j.1600-065X.2001.1820102.x.
  • Palomares O, Yaman G, Azkur AK, Ak- Koc T, Akdis M, Akdis CA. Role of Treg in immune regulation of allergic diseases. Eur J Immunol 2010;40(5):1232–1240. doi:10.1002/eji.200940045.
  • Singh AM, Dahlberg P, Burmeister K, Evans MD, Gangnon R, Roberg KA, Tisler C, Dasilva D, Pappas T, Salazar L, et al. Inhaled corticosteroid use is associated with increased circulating T regulatory cells in children with asthma. Clin Mol Allergy 2013;11(1):1. doi:10.1186/1476-7961-11-1.
  • Hartl D, Koller B, Mehlhorn AT, Reinhardt D, Nicolai T, Schendel DJ, Griese M, Krauss-Etschmann S. Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007;119(5):1258–1266. doi:10.1016/j.jaci.2007.02.023.
  • Lee JH, Yu HH, Wang LC, Yang YH, Lin YT, Chiang BL. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 2007;148(1):53–63. doi:10.1111/j.1365-2249.2007.03329.x.
  • Furukawa T, Sakagami T, Koya T, Hasegawa T, Kawakami H, Kimura Y, Hoshino Y, Sakamoto H, Shima K, Tsukioka K, et al. Characteristics of eosinophilic and non-eosinophilic asthma during treatment with inhaled corticosteroids. J Asthma 2015;52(4):417–422. doi:10.3109/02770903.2014.975357.
  • Massoud AH, Kaufman GN, Xue D, Béland M, Dembele M, Piccirillo CA, Mourad W, Mazer BD. Peripherally generated Foxp3 regulatory T cells mediate the immunomodulatory effects of IVIg in allergic airways disease. JI 2017;198(7):2760–2771. doi:10.4049/jimmunol.1502361.
  • Jadidi-Niaragh F, Mirshafiey A. The deviated balance between regulatory T cell and Th17 in autoimmunity. Immunopharmacol Immunotoxicol 2012;34(5):727–739. doi:10.3109/08923973.2011.619987.
  • Ma L, Xue HB, Guan XH, Shu CM, Wang F, Zhang JH, An RZ. The imbalance of Th17 cells and CD4+CD25highFoxp3+ Treg cells in patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2014;28(8):1079–1086. doi:10.1111/jdv.12288.
  • Huang F, Yin JN, Wang HB, Liu SY, Li YN. Association of imbalance of effector T cells and regulatory cells with the severity of asthma and allergic rhinitis in children. Allergy Asthma Proc 2017;38(6):70–77. doi:10.2500/aap.2017.38.4076.
  • Imani S, Salimian J, Fu J, Ghanei M, Panahi Y. Th17/Treg-related cytokine imbalance in sulfur mustard exposed and stable chronic obstructive pulmonary (COPD) patients: correlation with disease activity. Immunopharmacol Immunotoxicol 2016;38(4):270–280. doi:10.1080/08923973.2016.1188402.
  • Zheng S, Yu Q, Zeng X, Sun W, Sun Y, Li M. The influence of inhaled corticosteroid discontinuation in children with well-controlled asthma. Medicine 2017;96(35):e7848. doi:10.1097/MD.0000000000007848.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.